Search research articles
Contact Us
Filters
Showing results (71-80 of 74) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 74 results.
Frontiers in Oncology
|
December 26, 2022
A differential process mining analysis of COVID-19 management for cancer patients
Michel A Cuendet, Roberto Gatta, Alexandre Wicky, et al.
International Journal of Environmental Research and Public Health
|
September 16, 2020
What Role Can Process Mining Play in Recurrent Clinical Guidelines Issues? A Position Paper
Roberto Gatta, Mauro Vallati, Carlos Fernandez-Llatas, et al.
Nature Cancer
|
February 5, 2022
Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma
Lisa Haas, Anais Elewaut, Camille L Gerard, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 17, 2021
Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy
E Ghisoni, A Wicky, H Bouchaab, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 74) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 74 results.
Frontiers in Oncology
|
December 26, 2022
A differential process mining analysis of COVID-19 management for cancer patients
Michel A Cuendet, Roberto Gatta, Alexandre Wicky, et al.
International Journal of Environmental Research and Public Health
|
September 16, 2020
What Role Can Process Mining Play in Recurrent Clinical Guidelines Issues? A Position Paper
Roberto Gatta, Mauro Vallati, Carlos Fernandez-Llatas, et al.
Nature Cancer
|
February 5, 2022
Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma
Lisa Haas, Anais Elewaut, Camille L Gerard, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 17, 2021
Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy
E Ghisoni, A Wicky, H Bouchaab, et al.
Page
of 8